Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants

Bone Marrow Transplant. 2023 Feb;58(2):209-211. doi: 10.1038/s41409-022-01850-z. Epub 2022 Oct 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Artesunate / therapeutic use
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus Infections* / etiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Virus Activation

Substances

  • Artesunate